Tubastatin A HCl

For research use only.

Catalog No.S2627

23 publications

Tubastatin A HCl Chemical Structure

CAS No. 1310693-92-5

Tubastatin A HCl is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more).

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 160 In stock
USD 120 In stock
USD 270 In stock
USD 470 In stock
USD 870 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Tubastatin A HCl has been cited by 23 publications

Purity & Quality Control

Choose Selective HDAC Inhibitors

Biological Activity

Description Tubastatin A HCl is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more).
Targets
HDAC6 [1]
(Cell-free assay)
HDAC8 [1]
(Cell-free assay)
15 nM 854 nM
In vitro

Tubastatin A is substantially selective for all 11 HDAC isoforms and maintains over 1000-fold selectivity against all isoforms excluding HDAC8, where it has approximately 57-fold selectivity. In homocysteic acid (HCA) induced neurodegeneration assays, Tubastatin A displays dose-dependent protection against HCA-induced neuronal cell death starting at 5 μM with near complete protection at 10 μM. [1] At 100 ng/mL Tubastatin A increases Foxp3+ T-regulatory cells (Tregs) suppression of T cell proliferation in vitro. [2] Tubastatin A treatment in C2C12 cells would lead to myotube formation impairment when alpha-tubulin is hyperacetylated early in the myogenic process; however, myotube elongation occurs when alpha-tubulin is hyeperacetylated in myotubes. [3] A recent study indicates that Tubastatin A treatment increases cell elasticity as revealed by atomic force microscopy (AFM) tests without exerting drastic changes to the actin microfilament or microtubule networks in mouse ovarian cancer cell lines, MOSE-E and MOSE-L. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
neuron cultures MlTqT4lv[XOnIHHzd4F6 NG\EdGQzNjVizszN Mo\aSG1UVw>? MXXpcoR2[2W|IN8xMZR2[nWuaX6gbJlx\XKjY3X0fYxifGmxbh?= NVrHVZlJOjB4MUS5N|Y>
neuron cultures MXHGeY5kfGmxbjDhd5NigQ>? M1jT[J4yOCEQvF2= Ml7mSG1UVw>? M3HaS5Bzd3SnY4TzJIFo[Wmwc4Sg[4x2fGG2aHnvcoUh\GWybHX0bY9vNWmwZIXj[YQhd3irZHH0bZZmKHO2cnXzdy=> NH3teGMzODZzNEmzOi=>
134/04 MYHGeY5kfGmxbjDhd5NigQ>? MXm3MlUhyrWP M4PxNolueGGrcoOgcZlwfHWkZTDmc5Ju[XSrb36= MlGyNlIyPzR6M{m=
C2C12 MVzGeY5kfGmxbjDhd5NigQ>? MYq3MlUhyrWP MofLbY1x[Wm{czDtfY91fWKnIH\vdo1ifGmxbh?= M3zMcFIzOTd2OEO5
HaCaT keratinocytes MmHNSpVv[3Srb36gZZN{[Xl? MVixNEDPxE1? MWDicI9kc3NiYYLz[Y5qfGViZoLvcUBqdmS3Y3nu[{BPemZ{IIDyc5RmcW5idILhcpNt[XSrb36= MnyxNlI{Pjd4OEm=
JURL-MK1 MWXGeY5kfGmxbjDhd5NigQ>? MmmxNVAh|ryP NXrKRnZK\W6qYX7j[ZMh[2WubDDh[Ihme2m4aYT5JJRwKG[rYoLvcoVkfGmw M3nmSFI{ODJ{NUiz
CML-T1 NFzneZdHfW6ldHnvckBie3OjeR?= MWGxNEDPxE1? M1P2fYVvcGGwY3XzJINmdGxiYXTo[ZNqfmm2eTD0c{BncWK{b37lZ5Rqdg>? MYGyN|AzOjV6Mx?=
K562 M{TUNGZ2dmO2aX;uJIF{e2G7 NYDKVI1EOTBizszN MnzX[Y5p[W6lZYOgZ4VtdCCjZHjld4l3cXS7IITvJIZq[nKxbnXjeIlv Mk\yNlMxOjJ3OEO=
HL-60 MUXGeY5kfGmxbjDhd5NigQ>? NWrPcGZOOTBizszN NWTjR|hG\W6qYX7j[ZMh[2WubDDh[Ihme2m4aYT5JJRwKG[rYoLvcoVkfGmw M1fqVlI{ODJ{NUiz
KMCH NYL4Ull{T3Kxd4ToJIlvcGmkaYTvdpkh[XO|YYm= M1\kXp4yOCEQvF2= MmPr[IVkemWjc3XzJJBzd2yrZnXyZZRqd25iYX7kJIFv[2ixcnHn[U1qdmSncHXu[IVvfCCpcn;3eIg> NXrqXoNSOjN|N{CzNlc>
THP-1 M2W1XWZ2dmO2aX;uJIF{e2G7 NYfUNGhQhjFyIN88US=> NWrhU49WcW6qaXLpeJMhXE6ILd8xJIFv\CCLTD22JJNm[3KndHnvci=> NGe0UlEzOzV2MU[zOC=>
RAW 264.7 NGjQNm1HfW6ldHnvckBie3OjeR?= NXj3e|lUhjFyIN88US=> MkHyZZR1\W63YYTld{BPVyCycn;keYN1cW:w M1nVb|I{PTRzNkO0
HT3 NVTYNoJNTnWwY4Tpc44h[XO|YYm= NWfUTYpDhjVizszN NETzUlRFVVOR NWXCZYZUcW6mdXPld{B1cGViZHnm[oVz\W62aXHsJO6yNXS3YoXsbY4h[WOndInsZZRqd25? M4P3[FI{Pjl6NE[4
SiHa MkKySpVv[3Srb36gZZN{[Xl? M{i2UZ42KM7:TR?= MoC1SG1UVw>? M3TqSYlv\HWlZYOgeIhmKGSrZn\ldoVvfGmjbDFOtU11fWK3bHnuJIFk\XS7bHH0bY9v MUGyN|Y6QDR4OB?=
CaSki NGTndZBHfW6ldHnvckBie3OjeR?= NVPVPHp3hjVizszN NIHuZ5FFVVOR M4W0Solv\HWlZYOgeIhmKGSrZn\ldoVvfGmjbDFOtU11fWK3bHnuJIFk\XS7bHH0bY9v Mn3INlM3QTh2Nki=
SiHa MUfGeY5kfGmxbjDhd5NigQ>? M3vZRp42KM7:TR?= M13nXWROW09? MlHsbY5pcWKrdIOgWIhieHOrZ3Hy[4lvNSCxcjDFS2YucW6mdXPl[EBUV0OHIHHjeIl3[XSrb36= M1fnR|I{Pjl6NE[4
CaSki MkDFSpVv[3Srb36gZZN{[Xl? NGDOdJl,PSEQvF2= M{\mPGROW09? MmnEbY5pcWKrdIOgWIhieHOrZ3Hy[4lvNSCxcjDFS2YucW6mdXPl[EBUV0OHIHHjeIl3[XSrb36= MYmyN|Y6QDR4OB?=
MCF-7 M2TzdGdzd3e2aDDpcohq[mm2b4L5JIF{e2G7 M4jmW|MxKM7:TR?= M4m4TWROW09? NXn0VXZwUUN3ME2xOUDPxE1? NHnaT4szOzd7OE[4NC=>
MCF-7 NV3Q[nVKTnWwY4Tpc44h[XO|YYm= NY\Sc|h7OzBizszN M{LVNWROW09? Mm[0bY5kemWjc3XzJJRp\SCvaXPyc5R2[nWuZTDhZ4V1gWyjdHnvckBt\X[nbD6= MWKyN|c6QDZ6MB?=
MCF-7 MYjGeY5kfGmxbjDhd5NigQ>? MYSzNEDPxE1? MUHEUXNQ NXvNWG9Ne3SjYnnsbZpmeyCvaXPyc5R2[nWuZYOgZYdicW6|dDDjc4xlNWmwZIXj[YQh\GWyb3z5cYVzcXqjdHnvci=> NULaSGFYOjN5OUi2PFA>
MCF-7 NG\abllHfW6ldHnvckBie3OjeR?= M3f5bVE2KM7:TR?= NXHIOnV5TE2VTx?= MnPqd5Ri[mmuaYrld{BucWO{b4T1ZpVt\XNiYXfhbY5{fCCwb3Pv[IF7d2ynLXnu[JVk\WRiZHnzZZN{\W2kbIm= MY[yN|c6QDZ6MB?=
MCF-7 NVL1V3pFTnWwY4Tpc44h[XO|YYm= NGPx[Jk{OCEQvF2= MoLISG1UVw>? NWe4[FRx[Wy2ZYLld{B1cGViYYPz[Y1jdHliZInuZY1q[3Nib3[gbY51\XKyaHHz[UBucWO{b4T1ZpVt\XN? MljhNlM4QTh4OEC=
MCF-7 NIjyXm1HfW6ldHnvckBie3OjeR?= M1y5PVMxKM7:TR?= MYDEUXNQ NIfRZ4VqdmO{ZXHz[ZMhfGinIHLpcoRqdmdib3[gTGRCSzZid3n0bEBqdnSncoDoZZNmKG2rY4LveJVjfWyncx?= MWqyN|c6QDZ6MB?=
PC12 M4\qXWZ2dmO2aX;uJIF{e2G7 NFOxTJl,OyEQvF2= NIr3flNFVVOR MXj1dE1z\We3bHH0[ZMh[W62aT3vfIll[XSrdnWg[4Vv\SCneIDy[ZN{cW:wIILlcIF1\WRidH:geJJidnOlcnnweIlwdiCoYXP0c5IhYEKSMYO= M{HT[VI1QTB7Nki2
PC12 MnzUS5Jwf3SqIHnubIljcXSxcomgZZN{[Xl? NIHsNXh,OyEQvF2= MVLEUXNQ MVry[ZZmenOnIFiyU|IucW6mdXPl[EBoem:5dHigbY5pcWKrdHnvci=> MYWyOFkxQTZ6Nh?=
HEK293T MnLySpVv[3Srb36gZZN{[Xl? M1HU[Z4{KM7:TR?= NIK2cFNFVVOR NHvjVWF2eC2{ZXf1cIF1\WRiWFLQNZMheHKxdHXpckBt\X[nbB?= NY\O[GFwOjR7MEm2PFY>
HEK293T M4rDV2Z2dmO2aX;uJIF{e2G7 NETJZ3R,OyEQvF2= NXrBdmQ{TE2VTx?= NI\EbWZl\WyjeYOgXGJROXNicILveIVqdiCmZXfyZYRifGmxbjD2bYEh[WOndInsZZRqd25vbXXkbYF1\WRicILveIVie2:vYXyg[IVoemGmYYTpc44> MYeyOFkxQTZ6Nh?=
Huh7 Mn2wSpVv[3Srb36gZZN{[Xl? NWHsR|VDhjVizszN MmXSSG1UVw>? MX3zeZBxemW|c3XzJJBzd2yrZnXyZZRqd25ib3[gbIVx[XSrdHnzJGMhfmm{dYOgdoVxdGmlb36ge4l1cCCHQ{WwJF0hOC5|IN88US=> NX\jc4hoOjVzMEizNlY>
SKMEL21 NFH3WHNIem:5dHigbY5pcWKrdH;yfUBie3OjeR?= NEnMb4d,PTByIH7N MknoSG1UVw>? NI\NZW1qdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44> NFrXOYIzPTl3N{ixNi=>
SKMEL103 NUD5[G9VT3Kxd4ToJIlvcGmkaYTvdpkh[XO|YYm= NEXyU4R,PTByIH7N MXXEUXNQ M{fPOolvcGmkaYTzJINmdGxicILvcIln\XKjdHnvci=> NFLzNWczPTl3N{ixNi=>
SKMEL28 M134OGdzd3e2aDDpcohq[mm2b4L5JIF{e2G7 M3XGWZ42ODBibl2= NHfOPZNFVVOR Mni2bY5pcWKrdIOgZ4VtdCCycn;sbYZmemG2aX;u NGD2VmYzPTl3N{ixNi=>
WM164 M3zTZ2dzd3e2aDDpcohq[mm2b4L5JIF{e2G7 MnrvglUxOCCwTR?= M1HXbWROW09? MX7pcohq[mm2czDj[YxtKHC{b3zp[oVz[XSrb36= NX:xclhWOjV7NUe4NVI>
WM1361a MVzHdo94fGhiaX7obYJqfG:{eTDhd5NigQ>? M2ntOJ42ODBibl2= M{\2d2ROW09? NVPmfpJKcW6qaXLpeJMh[2WubDDwdo9tcW[ncnH0bY9v NUDOXoMxOjV7NUe4NVI>
WM1366 NELaXFZIem:5dHigbY5pcWKrdH;yfUBie3OjeR?= M1\JSp42ODBibl2= M{nRXGROW09? Mk\EbY5pcWKrdIOgZ4VtdCCycn;sbYZmemG2aX;u MVmyOVk2PzhzMh?=
WM793 NXfueG5MT3Kxd4ToJIlvcGmkaYTvdpkh[XO|YYm= NEXGbFN,PTByIH7N M2PkOGROW09? NHzQdnhqdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44> M2W5SlI2QTV5OEGy
WM35 MlPNS5Jwf3SqIHnubIljcXSxcomgZZN{[Xl? NHTwV5R,PTByIH7N MYrEUXNQ NFToTmNqdmirYnn0d{Bk\WyuIIDyc4xq\mW{YYTpc44> NYDV[llROjV7NUe4NVI>
WM983a MoHCS5Jwf3SqIHnubIljcXSxcomgZZN{[Xl? MVX+OVAxKG6P M1T5SWROW09? MWrpcohq[mm2czDj[YxtKHC{b3zp[oVz[XSrb36= MmWyNlU6PTd6MUK=
WM793 NXTWXZVKTnWwY4Tpc44h[XO|YYm= NXS1fYx4hjZizszN NHHvXFBFVVOR NWjQdnp{cW6mdXPlJGcyKGG{cnXzeC=> MXyyOVk2PzhzMh?=
WM164 M{XlTGZ2dmO2aX;uJIF{e2G7 MVP+OkDPxE1? MUPEUXNQ MX\pcoR2[2ViR{GgZZJz\XO2 MXmyOVk2PzhzMh?=
WM983a M2XHfWZ2dmO2aX;uJIF{e2G7 NInNRXF,PiEQvF2= NEG0SnNFVVOR MmrobY5lfWOnIFexJIFzemW|dB?= M4rDb|I2QTV5OEGy
WM164 MVrGeY5kfGmxbjDhd5NigQ>? M1\EZp4{KM7:TR?= Mo\iSG1UVw>? NGXvcmdifWevZX70d{BmgHC{ZYPzbY9vKG:oIF3IR{BkdGG|czDJJIFv\CCvZXzhco9u[SCjc4PvZ4lifGWmIHHueIlo\W6| MnXuNlU6PTd6MUK=
WM983a MXLGeY5kfGmxbjDhd5NigQ>? MYD+N{DPxE1? NWi0O|ZVTE2VTx?= MWDheYdu\W62czDlfJBz\XO|aX;uJI9nKE2KQzDjcIF{eyCLIHHu[EBu\Wyjbn;tZUBie3OxY3nheIVlKGGwdHnn[Y5{ NGLjRm8zPTl3N{ixNi=>
IPC298 NHTpTFdHfW6ldHnvckBie3OjeR?= NYL5OXBxhjNizszN MmnmSG1UVw>? NVnKUHJD[XWpbXXueJMh\XiycnXzd4lwdiCxZjDNTGMh[2yjc4OgTUBidmRibXXsZY5wdWFiYYPzc4Nq[XSnZDDhcpRq\2Wwcx?= NV2xUJdpOjV7NUe4NVI>
SKMEL30 MYfGeY5kfGmxbjDhd5NigQ>? NEm4VFJ,OyEQvF2= M1HMfmROW09? M1\rXIF2\22nboTzJIV5eHKnc4Ppc44hd2ZiTVjDJINt[XO|IFmgZY5lKG2nbHHuc41iKGG|c3;jbYF1\WRiYX70bYdmdnN? M33WeVI2QTV5OEGy
TCa83 NXjOVnB3TnWwY4Tpc44h[XO|YYm= MkjYbY5lfWOnczDQWGVPKGW6cILld5Nqd25iYX7kJI1mdWK{YX7lJJRz[W6|bH;jZZRqd25? M2SyXlI3Ojd7M{Cz
293T NXq0U4p2TnWwY4Tpc44h[XO|YYm= MlraglIh|rypL33s M4rWU4lv\HWlZYOgVHRGViCneIDy[ZN{cW:wIHHu[EBu\W2kcnHu[UB1emGwc3zvZ4F1cW:w M1zFRlI3Ojd7M{Cz
SACC-83 MWjGeY5kfGmxbjDhd5NigQ>? NWCwNJc{hjJizsznM41t MYPpcoR2[2W|IGDUSW4h\XiycnXzd4lwdiCjbnSgcYVu[nKjbnWgeJJidnOub3PheIlwdg>? NGD0dJAzPjJ5OUOwNy=>
293T M2f1eWZ2dmO2aX;uJIF{e2G7 Mke5glIh|rypL33s M{\KO4lv\HWlZYOgVHRGViCjY3X0fYxifGmxbjDheEBMOTZ| M{m4[FI3Ojd7M{Cz
U-87 MG MYXGeY5kfGmxbjDhd5NigQ>? NGixTIp,OiEQvHevcYw> MXjpcohq[mm2czD0bIUhdWmpcnH0bY9vKGGwZDDpcpZie2mxbh?= MmrRNlYzPzl|MEO=
U-87 MG MkDGSpVv[3Srb36gZZN{[Xl? Mlr1glExKM7:TR?= M{jUfYlvcGmkaYTzJGFMXCCyaH;zdIhwenmuYYTpc44> NEXjVmQzPjJ5OUOwNy=>
U-87 MG NHq2RWlIem:5dHigbY5pcWKrdH;yfUBie3OjeR?= M2XsOp4yOCEQvF2= M4TEd4lvcGmkaYTzJINmdGxiZ4Lve5Rp NYPtc2dbOjZ{N{mzNFM>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
EGFR / p-AKT / AKT / p-ERK / ERK ; 

PubMed: 29665050     


In KYSE140 (C) and KYSE180 (D), Tubastatin treatment EGFR, AKT, phospho-AKT and phospho-ERK levels were decreased in tubastatin-treated cells compared with control group.

29665050
Immunofluorescence
α-tubulin / Acetylated tubulin ; 

PubMed: 23798680     


Effects of tubastatin A on microtubules and microtubule acetylation level are shown. MCF-7 cells were treated with different concentrations of tubastatin A for 24 h and processed for immunostaining with antibodies against α-tubulin (green) and acetylated tubulin (red). Scale bars, 10 μm.

HDAC6; 

PubMed: 23798680     


MCF-7 cells are treated with vehicle, 30 μm tubastatin A (TBA), or 240 nm TSA for 24 h and fixed and processed to visualize microtubules (red) and HDAC6 (green). Scale bar, 20 μm.

23798680
In vivo Daily treatment of Tubastatin A at 0.5mg/kg inhibits HDAC6 to promote Tregs suppressive activity in mouse models of inflammation and autoimmunity, including multiple forms of experimental colitis and fully major histocompatibility complex (MHC)-incompatible cardiac allograft rejection. [2]

Protocol

Kinase Assay:[1]
- Collapse

Enzyme Inhibition Assays:

Enzyme inhibition assays are performed by the Reaction Biology Corporation, Malvern, PA, using the Reaction Biology HDAC Spectrum platform. (www.reactionbiology.com) The HDAC1, 2, 4, 5, 6, 7, 8, 9, 10, and 11 assays use isolated recombinant human protein; HDAC3/NcoR2 complex is used for the HDAC3 assay. Substrate for HDAC1, 2, 3, 6, 10, and 11 assays is a fluorogenic peptide from p53 residues 379-382 (RHKKAc); substrate for HDAC8 is fluorogenic diacyl peptide based on residues 379-382 of p53 (RHKAcKAc). Acetyl-Lys (trifluoroacetyl)-AMC substrate is used for HDAC4, 5, 7, and 9 assays. Tubastatin A is dissolved in DMSO and tested in 10-dose IC50 mode with 3-fold serial dilution starting at 30 μM. Control Compound Trichostatin A (TSA) is tested in a 10-dose IC50 with 3-fold serial dilution starting at 5 μM. IC50 values are extracted by curve-fitting the dose/response slopes.
Cell Research:[1]
- Collapse
  • Cell lines: Primary cortical neuron of fetal Sprague-Dawley rats (embryonic day 17)
  • Concentrations: 0-10 μM
  • Incubation Time: 24 hours
  • Method: Primary cortical neuron cultures are obtained from the cerebral cortex of fetal Sprague-Dawley rats (embryonic day 17) as described previously. All experiments are initiated 24 hours after plating. Under these conditions, the cells are not susceptible to glutamate-mediated excitotoxicity. For cytotoxicity studies, cells are rinsed with warm PBS and then placed in minimum essential medium (Invitrogen) containing 5.5 g/L glucose, 10% fetal calf serum, 2 mM L-glutamine, and 100 μM cystine. Oxidative stress is induced by the addition of the glutamate analogue homocysteate (HCA; 5 mM) to the media. HCA is diluted from 100-fold concentrated solutions that are adjusted to pH 7.5. In combination with HCA, neurons are treated with Tubastatin A at the indicated concentrations. Viability is assessed after 24 hours by MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method.
    (Only for Reference)
Animal Research:[2]
- Collapse
  • Animal Models: Na?ve CD45RBhi CD4+ CD25- cells (1 × 106) from WT or HDAC6-/- mice Are injected i.p. into B6/Rag1-/-mice.
  • Dosages: 0.5 mg/kg
  • Administration: Tubastatin A is injected i.p. daily.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 74 mg/mL (198.99 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5%DMSO+40%PEG300+5%Tween80+50%ddH2O
For best results, use promptly after mixing.
5.5 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 371.86
Formula

C20H21N3O2.HCl

CAS No. 1310693-92-5
Storage powder
in solvent
Synonyms N/A
Smiles CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

HDAC Signaling Pathway Map

HDAC Inhibitors with Unique Features

Related HDAC Products

Tags: buy Tubastatin A HCl | Tubastatin A HCl supplier | purchase Tubastatin A HCl | Tubastatin A HCl cost | Tubastatin A HCl manufacturer | order Tubastatin A HCl | Tubastatin A HCl distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID